Profile for World Intellectual Property Organization (WIPO) Patent: 2006002421
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2006002421
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | May 20, 2027 | Vertex Pharms Inc | TRIKAFTA (COPACKAGED) | elexacaftor, ivacaftor, tezacaftor; ivacaftor |
| ⤷ Start Trial | May 20, 2027 | Vertex Pharms Inc | ALYFTREK | deutivacaftor; tezacaftor; vanzacaftor calcium |
| ⤷ Start Trial | May 20, 2027 | Vertex Pharms Inc | SYMDEKO (COPACKAGED) | ivacaftor; ivacaftor, tezacaftor |
| ⤷ Start Trial | Aug 5, 2027 | Vertex Pharms Inc | TRIKAFTA (COPACKAGED) | elexacaftor, ivacaftor, tezacaftor; ivacaftor |
| ⤷ Start Trial | Aug 5, 2027 | Vertex Pharms Inc | ALYFTREK | deutivacaftor; tezacaftor; vanzacaftor calcium |
| ⤷ Start Trial | Aug 5, 2027 | Vertex Pharms Inc | SYMDEKO (COPACKAGED) | ivacaftor; ivacaftor, tezacaftor |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
